Quantify Publishes Paper on Cost-Effectiveness of Patiromer in Combination with RAAS Inhibitors for CKD in Sweden in PharmacoEconomics

The paper ‘Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden’, co-authored by Quantify, has been published in PharmacoEconomics. Read the full article here.